Redefining Drug Discovery Through Bio-Native AI MindWalk Holdings Corp.BATS:HYFTKalaGhaziIn the rapidly evolving landscape of biotechnology, a new category of company is emerging: one that treats biology not as a collection of disparate data types but as a unified, computable system. MindWalk is at the forefront of this movement, operating as a bio-native AI company whose mission is to transform the way drugs are discovered and developed. By embedding artificial intelligence within the biological context from the ground up, MindWalk aims to overcome the fragmentation that has historically plagued computational approaches to drug discovery. The Foundational Innovation: Patented HYFT® Technology At the heart of MindWalk's capabilities is its patented HYFT® technology. HYFT® represents a fundamental advance in how biological information is represented and processed. Traditional approaches often treat sequence data, structural information, functional assays, and scientific literature as separate domains that must be manually integrated. HYFT® breaks down these silos by creating a unified computational language that can simultaneously represent all of these dimensions. This enables the platform to capture the full complexity of biological systems, from the molecular details of protein folding to the population-level implications of genetic variation. The Integrated Platform: LensAI™ Built atop the HYFT® foundation is the LensAI™ platform, MindWalk's integrated operating environment for biological discovery. LensAI™ provides researchers with a suite of tools for querying, analyzing, and manipulating biological data within the unified framework established by HYFT®. The platform is designed to support the full spectrum of discovery activities, from early-stage target identification through late-stage candidate optimization. By providing a consistent interface to diverse data types, LensAI™ enables researchers to ask questions that would be difficult or impossible to answer using traditional, fragmented tools. Closing the Loop: The Integrated Full-Stack Wet Lab What truly distinguishes MindWalk from purely computational approaches is its commitment to closing the experimental loop. The company operates a fully integrated, full-stack wet laboratory that works in concert with its AI platforms. This physical infrastructure enables rapid validation of computational predictions, ensuring that insights generated in silico are grounded in experimental reality. Equally important, data generated in the wet lab flows back into the AI models, continuously improving their accuracy and expanding their capabilities. This creates a virtuous cycle of prediction, validation, and learning that accelerates over time. Applications Across the Discovery Value Chain The combination of HYFT®, LensAI™, and integrated wet lab capabilities enables a diverse array of applications critical to modern biotherapeutics development: Rapid Epitope Mapping: The platform can quickly identify the specific regions of target proteins that are recognized by antibodies, accelerating the development of both therapeutic and diagnostic agents. De Novo Molecular Design: Rather than searching through existing chemical space, MindWalk's AI can generate novel molecular structures optimized for specific therapeutic goals, expanding the universe of potential drug candidates. In Silico Vaccine Exploration: The platform enables rapid exploration of vaccine candidates, allowing researchers to evaluate immunogenicity, stability, and manufacturability before committing to wet lab experimentation. Population-Scale Biologics Analytics: By analyzing how candidate molecules interact with diverse genetic backgrounds, the platform helps researchers identify potential efficacy or safety issues across different patient populations, reducing the risk of late-stage clinical failures. A Platform for Speed and Insight In an industry where the cost of failure is measured in years and billions of dollars, the ability to move rapidly from insight to validated candidate is not merely advantageous—it is essential. MindWalk's bio-native AI platform, combined with its integrated wet lab, offers a path to greater efficiency and higher probability of success. By unifying biological data, enabling rapid in silico exploration, and closing the loop with physical validation, MindWalk is building the infrastructure for a new era of drug discovery. About MindWalk MindWalk is a bio-native AI company dedicated to transforming drug discovery and development. Powered by patented HYFT® technology and the LensAI™ platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.